Activin A does not directly alter the formation of ADM, but inhibits the proliferation of ADM and limits the expansion and proliferation of PDA cells through the modulation of p16 or p21 expression, which critically impacts senescence among preneoplastic ADM cells [63]. The gene discussed is CDKN2A; the disease is Patent ductus arteriosus.